Vitamin D: A new player in the world of mTOR signaling

Cell Cycle

Volumn 10, Issue 12, 2011, Pages 1888-1889

  Lisse, Thomas S ^a   Hewison, Martin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; EVEROLIMUS; MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN; TEMSIROLIMUS; VITAMIN D;

DRUG EFFECT; DRUG MECHANISM; EDITORIAL; GRAFT REJECTION; HORMONE ACTION; HUMAN; KIDNEY CARCINOMA; NONHUMAN; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 79959262669     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.12.15620     Document Type: Editorial

References (11)

1. Plum LA, et al. Nat Rev Drug Discov 9:941-55.
2. Lisse TS, et al. FASEB J 2011; 25:937-47.
3. Zoncu R, et al. Nat Rev Mol Cell Biol 12:21-35.
4. Bai X, et al. Science 2007; 318:977-80.
5. Ellisen LW. Cell Cycle 2005; 4:1500-2.
6. Wan C, et al. Proc Natl Acad Sci USA 2008; 105:686-91.
7. O'Kelly J, et al. J Steroid Biochem Mol Biol 2006; 100:107-16.
8. Yang J, et al. Exp Hematol 38:666-76.
9. Powell JD, et al. Immunity 33:301-11.
10. Adams JS, et al. Nat Clin Pract Endocrinol Metab 2008; 4:80-90.
11. Harrison DE, et al. Nature 2009; 460:392-5.